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Highlights 
? Ferrate(VI) at pH 6 with 3 mg/L is effective to remove the studied pharmaceuticals. 
? Toxicity was assessed using Bio-fix luminescent test and zebrafish animal model. 
? Simvastatin at 10μg/L exhibited high toxicity in comparison with other 
pharmaceuticals. 
? Ferrate(VI) treatment significantly reduced the toxicity of simvastatin  
? Ferrate(VI) itself did not produce additional toxicity after dosing into the test 
solutions 
Abstract  
Micro-pollutants in aquatic environment are an emerging challenge to the human health and 
ecosystems. This study was to investigate the acute toxicity before and after ferrate(VI) 
treatment for four pharmaceuticals (simvastatin, ivermectin, fluoxetine and oxytetracycline) 
at concentrations of 10 and 100 μg/L, respectively.  Zebrafish animal model and Vibrio 











the stated methods to assess toxicity of the selected pharmaceuticals before and after 
ferrate(VI) treatment when biochemical responses of catalase (CAT), tumour necrosis factor 
alpha (TNF-α), interleukin 1 beta (IL-1β) and B-cell lymphoma 2 (Bcl-2) were assessed in 
the zebrafish model. The results firstly revealed a significant change in the gene expression of 
CAT (p<0.001), TNF-α SOD 1 (p<0.01), and Bcl-2 (p<0.05) for simvastatin at low 
concentrations, which exhibited high toxicity in comparison with other pharmaceuticals. 
Ferrate(VI) treatment significantly reduced the toxicity of simvastatin by partially removing 
it during the treatment process and ferrate(VI) itself did not produce additional toxicity in the 
effluent.  
Keywords 
Ferrate(VI),   pharmaceuticals, toxicity assessment, waste water treatment, zebrafish 
1. Introduction 
Pharmaceuticals and personal care products (PPCPs) are used for health or cosmetic reasons,  
including therapeutic and veterinary drugs, fragrances, and cosmetics [1]. PPCPs and 
endocrine disrupting chemicals are categorized as micro-pollutants, which have been detected 
and persist in water bodies throughout the world [2]. The impact of micro-pollutants on 
environment is always controversial. The recent identification of new compounds which can 
cause an adverse effect on aquatic animals has raised serious concerns in the scientific 
community. The removal of micro-pollutants has become quite challenging to the wastewater 
industries as they are present in water at a very low concentration ranging from several ng/L 
to μg/L. Ozonation, nanofiltration, activated carbon absorption and reverse osmosis are 
widely executed in process of removal of micro-pollutants from waste waters. Though these 
technologies exhibited a significant performance in the removal of micro-pollutants they are 
not 100% efficient in most of the cases [3]. In search of more efficient technologies, one of 
the efforts is to develop and use the ferrate(VI) technology. Ferrate(VI) exhibits dual roles as 
oxidation and coagulation in water and waste water treatment [4] and recent studies showed 











Pharmaceutical chemicals are referred as drugs which can be a single or combination of 
substances and are administered to restore, correct or modify physiological functions by an 
immunological, pharmacological, or metabolic action [11, 12]. Simvastatin (Sim) is a 
member of statin’s group of hypolipidemic drugs, which  is most commonly prescribed drug 
in the treatment of coronary heart diseases Simvastatin is found in low concentrations in the 
environment but only limited data are available in regards to toxicity [3].  
Ivermectin (Ive) is one of the most commonly used anti-parasitic agents in domestic 
and agricultural activities. The Ivermectin passes into the environment in the unmetabolized 
form as faeces, which is harmful and poses a high risk for the environment [13]. 
Fluoxetine (Flu) is a member of the serotonin reuptake inhibitors (SSRI) class of 
antidepressants. It is widely spread in many countries and a study show presence of 
fluoxetine in effluents of 162 wastewater treatment works. Fluoxetine is found in several ng/l 
in water bodies and only limited data on toxicity is available [14].
Oxytetracycline (Oxy) is one of the widely used antibiotics to treat or prevent diseases 
in human and veterinary medicine. Oxytetracycline can reach environment through faeces of 
treated animals or feed itself. Certain studies showed that high concentration of antibiotics 
can destroy aquatic organisms such as fish, invertebrates and algae [15]. Properties of the 
pharmaceuticals for this study are shown in Supplemental Material, Table S1. 
Zebrafish (Danio rerio) is a tropical fish belonging to the family Cyprinidae. It is 
widely  used and an attractive model in toxicity testing because of its unique features such as 
easy maintenance of fish facility in labs, production of eggs in large number, transparent eggs 
for easy observation, rapid growth of embryos to adult fish, very sensitive to chemicals, and 
the genome is fully sequenced [2]. Recent studies reported that the exposure of 
pharmaceuticals caused a change in expression of certain genes such as cholinesterase (ChE), 
catalase (CAT), lactate dehydrogenase (LDH), vitellogenin (VTG), serotonin transport 
protein (SERT), 5-hydroxytryptamine 1A (5HT1A), and glutathione S- transferase (GST) 
activity [13, 16].
Although a number of researches have paid attention to using ferrate(VI) to treat 
various emerging micro-pollutants and some work reported also to assess the relevant toxicity 
of the treated effluents, a little of the work has been known to assess the eco-toxicity of 











[6]. In this study, the performance of ferrate(VI) to remove the four pharmaceuticals with low 
concentrations was evaluated. Moreover, the toxicity of the effluent consisting of the stated 
drugs before and after ferrate (VI) treatment was assessed using zebrafish animal model and 












2. Materials and methods 
2.1. Test chemicals 
The studied pharmaceutics (simvastatin,  ivermectin,  fluoxetine and  oxytetracycline) were 
purchased from Sigma Aldrich, which all comply with the European Pharmacopoeia 
Reference Standard.  Other chemicals, methanol (≥ 99.9%), potassium ferrate(VI) (> 90%), 
acetonitrile (99.8%), fluorescein dye (95%), acridine orange dye (75%) and qPCR kit were 
purchased from Sigma Aldrich.Solid-phase extraction (SPE) cartridge (200mg / 6mL, 1g / 
20mL) was purchased from Phenomenex, and deionised water was generated from B114 
deıonızer. . 
2.2. Solid-phase extraction (SPE) and UV/Vis spectroscopy measurement  
Stock solution (10 mg/L) of test chemicals was prepared using deionised reagent water. The 
model wastewater samples (10 and 100 μg/L, respectively) were prepared by diluting stock 
solution with tap water for the experiments. The quality of tap water was measured routinly 
during the test period which includes averaged pH of 6.9; DOC of 0.112 mg/L; and turbidity 
of 0.2 NTU. The properties of tap water in Scotland are also available in Scottish Water 
annual water quality report 
(https://www.scottishwater.co.uk/assets/domestic/files/you%20and%20your%20home/water
%20quality/annualwaterqualityreport2009.pdf) 
Samples were extracted using Phenomenex strata-X reversed phase cartridges. 
Cartridges were preconditioned and equilibrated. After loading sample it was washed, dried 
and then eluted using specific solvents as shown in Table 1. Final elute was 5 ml in volume 
and the flow rate of 5-10 ml per minute was maintained for the whole extraction process [5, 
17]. 
UV/Vis spectroscopy measurement is one of common methods that researchers to 
select to analyze concentrations pharmaceuticals [18 – 20]. This method was adapted in this 
work to analyze concentrations of the studied pharmaceuticals (at two concentrations, 10 and 
100 μg/L, respectively). Calibration curves for test chemicals were constructed using the 
same solvent from elution step in extraction procedure. Spectra scan of wavelength 200 and 
1100 nm was performed and strongest absorbance wavelength (λmax) was determined. 
Calibration was triplicated. By using λmax, the absorbance of each standard sample solution 











versus sample concentration. The λmax / calibration equation / correlation coefficient (R2) 
values were 238 nm/ y=12.788x/0.9936, 240 nm/ y=27.029x/0.9965, 
226nm/Y=48.098x/0.9709 and 364nm/ Y=36.528x/0.9984 for Simvastatin, Ivermectin, 
Fluoxetine and Oxytetracycline respectively. In a calibration equation, y is the detected 
absorbance and x is the concentration of the test chemical. Detailed procedures and calibrated 
standards can be seen in Figures S1-S3 in Supplementary Material.
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2.3. Ferrate(VI) treatment  
Ferrate(VI) concentration was determined by dissolving commercial available potassium 
ferrate(VI) (Sigma) in 4M sodium hydroxide and measuring the absorbance of resulting 
solution at 505 nm [6]. 
The model test solutions (10 and 100 μg/L) were prepared and ferrate(VI) dose (1-5 
mg/L) was added. The pH (4-11) was adjusted using 0.05 M sodium hydroxide or 0.1M 
sulphuric acid and carried out by adding pre-determined volume of either acid or alkali 
simultaneously with the addition of ferrate(VI). Jar test was performed under following 
conditions: fast mixing (max rpm, 2 min) then slow mixing (40 rpm, 20 min) and 
sedimentation (60 min). Six-unit stirrer (Kemiraflocculator 2000, kemwater) was used for 
this purpose. The supernatants were collected, filtered  and analysed by SPE and UV/Vis 
spectrophotometer. Best working dose and pH of ferrate were determined by evaluating the 
residual concentrations of pharmaceuticals. 
2.4. Bio-fix luminescent bacterial test 
Bio-fix luminescent bacterial test was performed using freeze dried luminescent bacteria. 
This toxicity test was performed by using BioFix Lum-10 (ATP). The test involved 
preconditioning (preparation of solution for freeze dried bacteria, preparation of freeze dried 
Vibrio fischeri, addition of dry sodium chloride (NaCl) to sample to make 2% NaCl sample 
solutions), incubation for 15 min and recording the results. Saline solution and potassium 
chromate were positive and negative controls respectively. The test was performed and 
analysed according to BS EN ISO 11348-3:2008 [21]. 
2.5. Zebrafish toxicity assessment 
2.5.1. Fish care and maintenance 
Zebrafish eggs used in this study were breed and maintained at Glasgow Caledonian 
University (ZEBTEC, Tecniplast). The fish facility was maintained with constant flow of 
conditioned water (28 ± 0.5?C, pH7.5), ventilation and 14:10 light/dark cycle. The fish were 
fed with brine shrimp twice every day and over feeding was strictly avoided. The day before 
test, two females and males were placed in 1 L breeding chambers before start of dark cycle 











post fertilization (hpf) for quality. The healthy eggs were bleached with chlorine. The eggs 
were  incubated at 28 ± 0.5?C and used for the acute toxicity study [2].  
2.5.2. Embryotoxicity essay 
The eggs at 6hpf were divided according to the number of treatment groups (4 test chemicals 
10 & 100 μg/L with and without ferrate (2 & 3 mg/L) at pH4 & 6. Each treatment group of 
20 eggs was exposed to 5 mL of test solution, which was freshly prepared and replaced every 
24 hrs. This is to make sure that the real test concentration of these pharmaceuticals  always 
remains the same (either 100 μg/L or 10 μg/L, respectively)  within the exposure period till 
120hpf. Each test group was closely monitored for toxic endpoints throughout the treatment 
process.  
2.5.3. Quantitative real-time PCR (qRT-PCR)  
The embryos after treatment process were homogenized with 1 ml TRIzol® Reagent and 
incubated for 5 min at room temperature. This step allows complete dissociation of 
nucleoprotein complex. 200μL Chloroform was added, vigorously shaken for 30 sec and 
allowed to stand for 3 min.  All the tubes were then centrifuged at 12000 ×g for 15 min at  
4ºC . This resulted in phase separation. The top aqueous layer which contains RNA was 
separated, isopropanol (500 μL) was added and allowed to stand for 10 min. All the tubes 
were then centrifuged at 12000×g for 10 min at 4ºC. RNA pellet formed during 
centrifugation was retained and remaining contents were discarded. 75% ethanol was added 
to RNA pellet and  washed by centrifuging (7500 ×g, 10 min, 4º C). Ethanol was evaporated 
by  allowing it to stand at room temperature. The RNA pellet was resuspended with  RNase-
free water (25 μL) and incubated (15 minutes, 55-60º C). The RNA concentration was 
measured by using Nanodrop spectrophotometer. It was then stored at  -80 º C and used for 
cDNA synthesis.  
cDNA was synthesized from total RNA by using Roche Transcriptor High Fidelity 
cDNA Synthesis Kit according to manufacturer’s protocol. The cDNA concentration was 
measured using Nanodrop spectrophotometer. The Platinum® SYBR® Green qPCR Super 
Mix-UDG master mix was used to analyse gene expression according to manufacturers 
protocol.  
Biorad CFX96TM Real-Time PCR detection system was used for qRT-PCR which was 
performed by UDG incubation at 50°C for 2 min, Taq polymerase activation at 95°C for 2 











for 1 min. Fluorescence signal detection was measured at 72°C. Ct based relative 
quantification of a candidate gene was calculated by using 2- ΔΔCT  method and normalizing to 
Ct of the zebrafish 18s RNA gene. 
2.6. Statistical analysis 
GraphPad Prism (version 7.0 from GraphPad software Inc. San Diego, CA, USA) was used 
for statistical analysis. All comparisons were performed using one way ANOVA, non-
parametric test and Dennett’s multiple comparison test at 95% confidence interval. Statistical 
significance was considered when a level of p is less than 0.05. *p< 0.05; **p< 0.01; ***p< 
0.001; ****p<0.0001. 
3. Results and discussion 
3.1. Performance of ferrate (VI) 
The efficiency of ferrate(VI) to remove pharmaceuticals can be seen in Figure 1. For most 
cases, a ferrate(VI) dose of 3 mg Fe/L achieved higher percentage removal of all four 
pharmaceuticals. Among them, Fluoxetine was relatively removed efficiently (70%) in 
comparison with Ivermectin, which was removed by 25% only for the same operating 
conditions compared. Comparing with two starting pharmaceutical concentrations, 10 μg/L 
and 100 μg/L, slightly more removals for Sim, Flu and Oxy were achieved for the higher 
concentration samples but removal efficiency of Ive was the lowest no matter what starting 
concentration was. The efficiency of ferrate(VI) to remove individual compound from the 
mixture of four pharmaceuticals was almost the same as that from the single compound 
solution. The effect of pH on the pharmaceutical removal was studied by conducting 
experiments using initial 100μg/L pharmaceutical concentration samples (Sim, Ive , Flu and 
Oxy) and ferrate(VI) doses (1 to 3 mg/L) for the pH range of 4-10, when the best percentage 
removal was achieved at pH6 for most pharmaceuticals studied (Figure 2).  
The effect of solution pH on the removal of pharmaceuticals might be considered from 
ferrate(VI) speciation against solution pH. There are four ferrate(VI) species in aqueous 
solution that depend on pH: H3FeO4+, H2FeO4, HFeO4-, and FeO42-, and the corresponding 
dissociation constants are pK1 1.6±0.2, pK2 3.5, and pK3 7.23, respectively [22]. FeO42- is the 











conditions. Ferrate(VI) has a higher oxidation potential at low pH (2.2 V) than in the alkaline 
condition (0.72V) [4] and thus the lower the solution pH, the stronger oxidation potential of 
ferrate(VI) (HFeO4- predominates) although the stability of ferrate(VI) decreases at low pH 
solutions. 
The reactions of ferrate(VI) with some of pharmaceuticals have been studied in order to 
explore possibilities of using ferrate(VI) to remove pharmaceuticals from water and waste 
water [e.g., 23–25]. Pharmaceuticals studied include carbamazepine, sulfonamide 
antimicrobials, trimethoprim, tetracycline, ibuprofen, ciprofloxacin, enrofloxacin, and 
diclofenc. There are no published work for applying ferrate(VI) to degrade four 
pharmaceuticals chosen in this study and this research has thus explored the possibilities of 
this and attempted to obtain the optimal operating conditions. Future work aims to establish 
the stoichiometry and oxidation products of the reactions between these pharmaceuticals and 
ferrate(VI).  
3.2. Assessment of toxicity of ferrate treated samples 
3.2.1. Bio-fix luminescent bacterial test 
Bio-fix luminescent bacterial test results are shown in Figure 3. The concentration of samples 
was 100 μg/L at a pH range of 4 to 11 was performed. The result shows that all the Sim 
samples and samples at pH4, 10 and 11 were toxic when compared to positive control (saline 
blank) and negative control (potassium chromate). 
3.2.2. Embryotoxicity test
3.2.2.1. Acute toxicity testing 
In this study, the test process resulted in mortality, hatching delay, abnormalities (abnormal 
spinal cord formation, heart and yolk sac, pericardial oedema, and abnormal eye and tail 
formation), and a decrease of the heart beat in zebrafish embryos and the effect is specific to 
the type and concentration of pharmaceuticals studied and solution pHs. Sim has shown toxic 











mortality, heart rate and total abnormalities were significantly increased, whereas hatching 
was significantly decreased when compared to the control sample. After treatment with 
ferrate(VI) (2 and 3 mg/L), Sim still had toxicity although it was partially reduced, reflecting 
incomplete removal of Sim by ferrate(VI) from the test samples (Figure 4). However, 
simvastatin 10 μg/L showed a nonsignificant change in the mortality, hatching, heart rate and 
abnormalities when compared to the control (Figure 5). 
Sim (alone or mixture) was the most toxic test compound for zebrafish. It has clearly 
induced statistically significant effects even at a very low concentration (100 μg/L). It is very 
lethal even at 100 μg/L and resulted in 80% mortality. The results observed from this study 
are clearly identical to that was previously reported; that Sim with 500 and 5000 μg/L 
exposure to zebrafish embryos resulted in 100% mortality at 32 hpf [3]. Furthermore, lower 
hatching and heart rate was recorded when compared to the control. Although all the test 
compounds showed abnormalities, the number and severity of abnormalities were observed 
high with Sim. Bio-fix luminescent bacterial test also showed the similar results, Sim is the 
most toxic compound observed from this study when compared to other test compounds.  
Except Sim at 100 μg/L, other pharmaceuticals samples (100 μg/L) and all 10 μg/L 
samples exhibited no significant change in toxic end points (Figures 4 and 5). It is also 
clearly seen that the mixture of the four pharmaceuticals (10 μg/L each) caused some 
significant changes in mortality, hatching and total abnormalities (Figure 5). This may be 
because of the Sim in the mixture or may be by-products formed from interactions. However, 
long term exposure to a compound, an interaction with other compounds and the formation of 
by-products can’t be ruled out. 
The embryo toxicity study was also performed at pH4 and the results were shown in 
Figure 6. At pH4, all the test samples including the control sample showed significant 
toxicity when compared to the control sample at pH7. As pH4 control showed significant 
toxicity and pH 6 control did not, the pH range from 2 to 12 (without pharmaceuticals) was 
studied to determine the influence of pH on the toxicity (Figure 7). The result showed that the 
pH range from 2 to 4 and 10 to 12 were toxic and pHs5-9 was non-toxic, which is suitable for 
the zebrafish embryo growth. The importance and influence of pH can also be seen in Figure 
3.
Although there may be a difference in the tested concentration from that in the 











compared to other test compounds (Figures 4 and 5). Other three compounds, Ive, Oxy and 
Flu, at 10 μg/L, haven’t shown any toxic impact on zebrafish embryos (Figures 4 and 5). On 
the other hand, high concentration of Ive (100 μg/L) showed a significant increase in 
abnormalities (p< 0.05) when compared to the control sample and samples of Oxy (p> 0.05) 
and Flu (p> 0.05)  (Figure 4).  
3.2.2.2. Expression changes of anti-oxidant and inflammation genes  
Different environmental factors, including increased temperature and oxygen, salinity, 
transition metal ions, pesticides and pollutants, can induce oxidative stress in aquatic animals 
[26]. Chemicals, including pharmaceuticals, have been reported to cause oxidative stress in 
farm fish [27 – 29]. Sim (10 and 100 μg/L) caused significant changes in the expression of 
antioxidant gene (CAT), inflammation related gene (TNF-α) and apoptosis related gene (Bcl-
2). Ive (10 and 100 μg/L) showed significant change in CAT gene expression, whereas Flu, 
Oxy and ferrate(VI) by themselves showed no significant changes in expression of test genes.  
The mixture of four compounds (both 100 and 10 μg/L) showed significant effects on the 
expression of test genes (Figures 9 and 10). 
In this study, the expression of CAT gene was up-regulated significantly by Sim (10 
and 100 μg/L) after a 5-day exposure (Figures 8 and 9). Change in the expression of CAT 
gene was reported when zebrafish were exposed to atrazine, silver, copper, cadmium and zinc 
nanoparticles [27]. It is interesting to see that mixture of these compounds changed the 
expression of the entire test genes, showing significant toxicity when compared to the control 
sample and individual compounds (Figures 9 and 10).  
The identification of a large number of oxidative stress related genes in zebrafish has 
made the path easy for the researchers to study the impact of chemical pollutants and 
biological toxicity. For this reason, we have selected and examined the representative genes 
(SOD, CAT and GPX). This study helps to determine whether the selected genes have the 











The fish can fight against the elevated reactive oxygen species (ROS) levels in their 
body with SOD, CAT and GPX. They convert superoxide anions (O2-) into hydrogen 
peroxide (H2O2) and which is further converted to water (H2O) and oxygen (O2). Any change 
in the expression of these antioxidant enzymes may result in the excess H2O2 and other oxy-
radicals in the body [31]. It is also reported that the cells are capable of dealing with 
increased ROS levels up to a certain extent without any adverse effect on cellular viability or 
function. This might be the possible reason for the change in ROS-related gene expression to 
reduce the ROS levels in cells (compensatory mechanisms) and no toxicity (metabolic or 
cellular dysfunction) [30]. 
Figures 9 and 10 clearly show that the expression of Bcl-2 was inhibited by Sim and 
mixture solutions (10 and 100 μg/L, respectively). Similar results were reported after atrazine 
exposure [30]. Bcl-2 moves to the site and eradicate generated free radicals and this further 
reduces oxidative stress and prevents apoptosis. Liu et al. [32] and Deng et al. [33] reported 
inhibition of Bcl-2 mRNA expression in zebrafish by oxidative stress [30]. 
Flu (10 μg/L) has shown the change in the expression of SOD gene when compared to 
the control. The lower concentration might have stimulated the gene expression and might get 
reduced with the increase in the concentration of pharmaceutical. Similar results were 
reported by Jin et al. [30], where 10 and 100 μg/L of atrazine increased SOD, CAT and GPX 
expression, whereas 1000 μg/L did not show any change in the same genes [27]. 
IL-1β and TNF-α (proinflammatory cytokines) belongs to the cytokine family, they 
migrate to the sites of injury or infection as a response to the stimuli.  The expression of these 
genes in the samples represents injury or infection. Sim (100 μg/L) and mixture (10 and 100 
μg/L) showed a significant change in the expression of TNF-α gene (Figs.  9 and 10). The 
mixture (100 μg/L) has shown its influence on IL-1β gene expression. This may be because 
of the higher concentration of pharmaceuticals (100 μg/L each and 400 μg/L in total) in the 
medium or formation of by-products [34]
In Fig. 10, only Sim10 (Sim, 10 μg/L) and mix 10 (mixture solution of four compounds 
at concentration of 10 μg/L each) have shown changes in Bcl-2 gene expression. The 
presence of Sim in the mixture solution and interactions among four compounds,  resulting in 












3.2.2.3. Acridine Orange staining  
Apoptosis (cell death) was studied by using Acridine Orange staining. The bright spots in 
Figure 11 represent damage of the cells or body parts. The intensity of bright spots is directly 
proportional to the cellular damage hence toxicity. Staining showed bright spots in Sim and 
Ive group samples suggesting that these pharmaceuticals were toxic after 5-day fertilisation 
(Figure 11). 
In multicellular organisms, the cell count is very tightly regulated by controlling cell 
division and programmed cell death which is commonly called as apoptosis. Acridine orange 
can permeate apoptotic cells and binds to DNA where normal healthy cells are non-
permeable to acridine orange. The bright spots indicate the bond between acridine orange and 
cell DNA, a feature of apoptosis. From Figure 11, it is clearly seen that all the pharmaceutical 
samples in the study have caused apoptosis but the intensity of the cell damage varied. The 
intensity of apoptosis is directly proportional to bright spots in staining. It is interesting to see 
staining, particularly in the heart region of zebra fish in Sim and Ive cases. Certain studies 
reported that the myocyte apoptosis at a very low level can also cause dilated 
cardiomyopathy. A study reported that the accumulation of toxic test substance in the heart 
region of fish caused apoptosis. A study reported that the exposure to chemicals like 
hexabromocyclododecane (HBCD) and microcystins (MCs) on Zebrafish caused apoptosis in 
the heart area and retarded body growth. This suggests that the heart is a primary target for 
the pharmaceutical toxicity in zebrafish and this may lead to decrease in heart rate or failure 
in blood circulation and further slowing down the development of zebrafish [33, 35 – 37]. 
3.2.2.4. Fluorescein staining 
Sim (100 μg/L) and Ive (100 μg/L) showed increase in fluorescein signal inside the embryo 
after three days fertilisation. The staining signal was significant in case of Sim (100 μg/L) 
when compared to the control embryos in E3 medium. This is of evidence that Sim 100 μg/L 
is toxic enough to damage the embryo chorion membrane, helping fluorescein to pass through 
it (Figure 12). 
15 
The zebrafish has been shown as an important animal model in understanding of the 
chemical toxicity, human disease mechanisms and drug discovery. Coupled with in 
vivo fluorescent imaging agents, it is widely used for the visualization of specific tissues [38]. 
As fluorescein has very limited water solubility [39] and was not absorbed into the zebrafish 
from the medium, it was employed to visualize the drug uptake and accumulation onto the 
eggs of the zebrafish in this study.   
A study reported that zebrafish can absorb chemicals more efficiently from the 
surrounding medium into its body when the log P (octanol/water partition coefficient) of the 
chemical is more than 1 [35]. The fluorescence signal and absorption of the pharmaceuticals 
in the zebrafish may be correlated with their Log P values as a significant amount of Sim (log 
P = 4.51) and Ive (log P = 5.83) were absorbed (Figure 11). Moreover, the distribution of 
fluorescein in the egg varied with pharmaceutical used; Fluorescein itself or its mixture with 




For the study conditions reported in this paper, four pharmaceuticals (Sim, Ive, Flu and Oxy 
at low concentrations, 10 and 100 μg/L, respectively) can be removed up to 70% when 
dosing ferrate(VI) at 3 mg/L as Fe and controlling sample pH at 6. Increasing pH will 
decrease the removal efficiency due to less active ferrate(VI) species were present at high pH. 
Slightly more Sim, Flu and Oxy were removed in the higher concentration samples (100 
μg/L) but removal efficiency of Ive was the lowest no matter what starting concentration was.  
Toxicity was assessed based on the inhibition of light emission by test samples in the 
Vibrio fischeri Luminescent test, and developmental changes in the mortality, behaviour, and 
biochemical responses of CAT, TNF-α, IL-1β and Bcl-2 in the zebrafish model. Chemical 
permeability of zebrafish embryo chorion and apoptosis were determined by Fluorescein dye 
staining and Acridine orange staining respectively. Sim exhibited high toxicity in comparison 
with other pharmaceuticals. At pH6, Sim100 and Mix 100 showed the toxicity  in all studies. 
And also, Sim100 displayed changes in gene expression in all casaes except SOD and IL-1; 




SOD, and Bcl-2; and finally, Mix10 has changed the expression of  CAT, TNF, Bcl-2 genes. 
Finally, ferrate(VI) treatment significantly reduced the toxicity of Sim by partially removing 
it during the treatment process and ferrate(VI) itself did not show to produce additional 
toxicity in the effluent. 
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Fig. 1. Performance of ferrate(VI) to remove four pharmaceuticals at pH6 (sim = Simvastatin 
10 or 100 μg/L; Ive = Ivermectin 10 or 100 μg/L; Flu = Fluoxetine 10 or 100 μg/L; Oxy10 = 
Oxytetracycline 10 or 100 μg/L; XX mixed = individual compound in a mixture solution 
containing 4 compounds with concentration of 10 or 100 μg/L) 
Fig. 2. Influence of pH on the performance of ferrate to remove 100 μg/L of Simvastatin 
(Sim), Ivermectin (Ive), Fluoxetine (Flu) and Oxytetracycline (Oxy) 
Fig. 3. Influence of pharmaceuticals on bacterial bioluminescence with or without ferrate at 
pH4, 6, 10 and 11. 
Fig. 4. Effect of 100μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; and 
Oxy, oxytetracycline) at pH6 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 
and 3 mg/L) treatment. *p< 0.05; **p< 0.01; ***p< 0.001; ****p<0.0001 
Fig. 5. Effect of 10 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; and 
Oxy, oxytetracycline) at pH6 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 
and 3 mg/L) treatment. *p< 0.05; **p< 0.01 
Fig. 6. Effect of 100μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; and 
Oxy, oxytetracycline) at pH4 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 
and 3 mg/L) treatment. **p< 0.01; ***p< 0.001; ****p<0.0001 
Fig. 7. Effect of pH on zebrafish embryos mortality at 120 hpf. **p< 0.01; ****p<0.0001 
Fig. 8. Represents abnormalities in zebrafish development due to treatment with test samples 











abnormality in the development D, E and F shows abnormality in spinal cord formation; B 
and E shows abnormality in heart and yolk sac; C, E and F shows abnormality in tail 
formation. Control, A = Zebrafish embryo water; B and C = Ivermectin 100 μg/L treatment; 
D and E = Simvastatin 100 μg/L treatment; F and G = pH4 treatment; H = Fe 3 mg/L 
treatment and I = Dead egg. 
Fig. 9. Effect of 100μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine;  
Oxy, oxytetracycline) at pH6 on zebrafish embryos gene expression at 120 hpf before and 
after ferrate(VI) (2 and 3 mg/L) treatment.  
Control = Zebrafish embryo water. Ctrl Fe 2/3 mg/l = ferrate dose without pharmaceuticals. 
ctrl pH6= zebrafish embryo water adjusted to pH6. Results are shown in error bar as the 
mean ± standard deviation (SD). **** p<0.0001; *** p<0.001; **p<0.01; *p<0.05 
Fig. 10. Effect of 10 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; 
Oxy, oxytetracycline) at pH6 on zebrafish embryos gene expression at 120 hpf before and 
after ferrate(VI) (2 and 3 mg/L) treatment.  
Control = Zebrafish embryo water. Ctrl Fe 2/3 mg/L = ferrate dose without pharmaceuticals. 
ctrl pH6= zebrafish embryo water adjusted to pH6. Results are shown in error bar as the 
mean ± standard deviation (SD). **** p<0.0001; *** p<0.001; **p<0.01; *p<0.05 
Fig. 11. Acridine Orange staining: Apoptosis in zebrafish due to treatment with test samples 
at pH 6 (Simvastatin and Ivermectin). Bright spots represent apoptosis. A represents Sim 100 
μg/L treatment; B represents Ive 100 μg/L treatment; C represents Flu 100 μg/L treatment; D 
represents Oxy 100 μg/L treatment; E represents ferrate(VI) 3 mg/L treatment and F 
represents control. Control = Zebrafish embryo water. 
Fig. 12. Fluoresceın staining: Permeability of test samples (Sim and Ive) through zebra fish 
chorion after 24, 48 and 72 hours treatment. Fluorescence represents permeability. E3 














Figure 1. Performance of ferrate(VI) to remove four pharmaceuticals at pH6 (Sim = 
Simvastatin 10 or 100 μg/L; Ive = Ivermectin 10 or 100 μg/L; Flu = Fluoxetine 10 or 100 
μg/L; Oxy10 = Oxytetracycline 10 or 100 μg/L; XX mixed = individual compound in a 












Figure 2. Influence of pH on the performance of ferrate to remove 100 μg/L of Simvastatin 
(Sim), Ivermectin (Ive), Fluoxetine (Flu) and Oxytetracycline (Oxy 
 
Figure 3. Influence of pharmaceuticals on bacterial bioluminescence with or without 












Figure 4. Effect of 100 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; 
Oxy, oxytetracycline) at pH6 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 












Figure 5. Effect of 10 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine;  
Oxy, oxytetracycline) at pH6 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 







Figure 6. Effect of 100μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; 
Oxy, oxytetracycline) at pH4 on zebrafish embryos at 120 hpf before and after ferrate(VI) (2 








Figure 7. Effect of pH on zebrafish embryos mortality at 120 hpf. **p< 0.01; ****p<0.0001 
 
Figure 8. Represents abnormalities in zebrafish development due to treatment with test 
samples (Simvastatin and Ivermectin). A represents control and the remaining show some 
kind of abnormality in the development D, E and F shows abnormality in spinal cord 
formation; B and E shows abnormality in heart and yolk sac; C, E and F shows abnormality 
in tail formation. Control, A = Zebrafish embryo water; B and C= Ivermectin 100μg/L 
treatment; D and E= Simvastatin 100 μg/L treatment; F and G= pH4 treatment; H= Fe 3mg/L 










Figure 9. Effect of 100 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; 
Oxy, oxytetracycline) at pH6 on zebrafish embryos gene expression at 120 hpf before and 
after ferrate(VI) (2 and 3 mg/L) treatment.  
Control = Zebrafish embryo water. Control Fe 2&3 mg/L = ferrate dose without 
pharmaceuticals. Control pH6= zebrafish embryo water adjusted to pH6. Results are shown 













Figure 10. Effect of 10 μg/L test samples (Sim, simvastatin; Ive, ivermectin; Flu, fluoxetine; 
Oxy, oxytetracycline) at pH6 on zebrafish embryos gene expression at 120 hpf before and 
after ferrate (2 and 3 mg/L) treatment. 
Control = Zebrafish embryo water. Control Fe 2&3 mg/L = ferrate dose without 
pharmaceuticals. Control pH6 = zebrafish embryo water adjusted to pH6. Results are shown 







Figure 11. Acridine Orange staining: Apoptosis in zebrafish due to treatment with test 
samples at pH6 (Simvastatin and Ivermectin). Bright spots represent apoptosis. A represents 
Simvastatin 100 μg/L treatment; B represents Ivermectin 100 μg/L treatment; C represents 
Fluoxetine 100 μg/L treatment; D represents Oxytetracycline 100 μg/L treatment; E 













Figure 12. Fluoresceın staining: Permeability of test samples (Simvastatin and Ivermectin) 
through zebra fish chorion after 24, 48 and 72 hours treatment. Fluorescence represents 
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